about
Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiencyExpanding the clinical indications for α(1)-antitrypsin therapyQingfei Xiaoyan Wan alleviates asthma through multi-target network regulationLonger telomere length in COPD patients with α1-antitrypsin deficiency independent of lung functionPleiotropic functions of EAPII/TTRAP/TDP2: cancer development, chemoresistance and beyondiTRAQ-based proteomic analysis of hepatic tissues from patients with hepatitis B virus-induced acute-on-chronic liver failure.α1-Antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice.Proteomic analysis of plasma from rats following total parenteral nutrition-induced liver injury.
P2860
Q24619820-C9E56400-636E-4B43-96F3-887F7EAFFBE7Q27000764-6976DC35-1868-43E0-81DB-342E12A554A0Q30544207-B6D690F9-E911-4FDB-99BC-1F4C7D612179Q35156969-25CFB1CE-85A1-40B1-9FB2-AA72F566FDD6Q35600743-E7E92CB2-2724-4CE7-AF62-8D91E0F058FBQ36334771-5A2D7E9D-3F33-4137-BF10-A693FBC77C22Q37313010-7C0BB159-CF68-4355-978D-FE33ADCFE859Q51337626-C306CD73-5B24-4FB0-A8BB-0AE8BF431FF8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
α(1)-antitrypsin deficiency and inflammation.
@en
type
label
α(1)-antitrypsin deficiency and inflammation.
@en
prefLabel
α(1)-antitrypsin deficiency and inflammation.
@en
P2860
P356
P1476
α(1)-antitrypsin deficiency and inflammation.
@en
P2093
David A Lomas
Ugo I Ekeowa
P2860
P304
P356
10.1586/ECI.10.95
P577
2011-03-01T00:00:00Z